| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |